Receiving an mRNA COVID-19 vaccine within 100 days of starting ICI therapy may improve overall survival in some patients with cancer.

Treatment with baloxavir marboxil significantly reduced the risk of onward transmission of influenza within households.

For patients with advanced melanoma, there is a survival benefit for nivolumab plus ipilimumab and for nivolumab monotherapy compared with ipilimumab monotherapy.

Surgery was the most effective treatment for cutaneous squamous cell carcinoma in situ, however, variations among other treatment approaches exist.

Advancements in laser technologies for skin rejuvenation in various skin conditions was shown to be safe, efficacious, and satisfactory to patients.

COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common.

The US Vaccines for Children program has prevented millions of cases of illness, hospitalizations, and deaths, resulting in massive direct and societal savings.

The fungal skin disease burden has increased from 1990 to 2021, with those in underdeveloped regions and some children and older adults most affected.

Nivolumab plus ipilimumab can provide long-term benefits to patients with advanced melanoma, according to a 10-year update of the CheckMate 067 trial.

Most patients with previously biopsied basal cell carcinoma and squamous cell carcinoma have residual tumor at the time of Mohs micrographic surgery.

After infection, prevalent metformin use is associated with a slightly lower incidence of mortality or long COVID.

Interviews with parents of deceased children with cancer revealed preferences for a balance of comfort and continued care at end of life.